Basics Guardant Health, Inc. IPO Date: October 1, 2018 Sector: Healthcare Industry: Diagnostics and Research Market Cap: $5.96B Activated in VL: True Average Daily Range Avg Daily Range: $1.69 | 2.80% Avg Daily Range (30 D): $0.78 | 1.59% Avg Daily Range (90 D): $1.11 | 2.49% Institutional Daily Volume Avg Daily Volume: 1.26M Avg Daily Volume (30 D): 1.6M Avg Daily Volume (90 D): 1.77M Trade Size Avg Trade Size (Sh.): 71 Avg Trade Size (Sh.) (30 D): 56 Avg Trade Size (Sh.) (90 D): 59 Institutional Trades Total Inst.Trades: 7,197 Avg Inst. Trade: $3.05M Avg Inst. Trade (30 D): $3.68M Avg Inst. Trade (90 D): $3.3M Avg Inst. Trade Volume: .06M Avg Inst. Trades (Per Day): 4 Market Closing Trades Avg Closing Trade: $6.3M Avg Closing Trade (30 D): $14.1M Avg Closing Trade (90 D): $11.58M Avg Closing Volume: 126.87K     News Jun 12, 2025 @ 8:58 AM Molecular Diagnostics for Cancer Market Research 2... Source: Researchandmarkets.Com Jun 3, 2025 @ 5:31 PM Epigenetics Market Anticipated to Achieve 11.8% CA... Source: Bcc Research May 16, 2025 @ 11:30 PM Guardant Health: A Promising Player in the Liquid ... Source: The Motley Fool Apr 24, 2025 @ 7:36 PM Guardant Health, Pfizer Collaborate To Develop New... Source: Vandana Singh Apr 8, 2025 @ 8:48 AM Minimal Residual Disease Testing Market Forecast R... Source: Researchandmarkets.Com Financials   TTM Q1 2025 Q4 2024 Basic EPS $-3.39 $-.77 $-.9 Diluted EPS $-3.39 $-.77 $-.9 Revenue $ 774M $ 203.47M $ 201.81M Gross Profit $ $ 128.75M $ Net Income / Loss $ -416.55M $ -95.16M $ -111.01M Operating Income / Loss $ -454.95M $ -111.04M $ -125.97M Cost of Revenue $ $ 74.72M $ Net Cash Flow $ -323.63M $ 174.1M $ -56.84M PE Ratio